Main navigation About Tolmar Science & Innovation Treatments Responsibility Careers News Contact Contact Contact Us Tolmar welcomes your comments and questions. Find contact information for our headquarters offices in Illinois and Northern Colorado. Product Development and Manufacturing 701 Centre Ave Fort Collins, CO 80526 970-212-4500 1-877-9TOLMAR (1-877-986-5627) info@tolmar.com U.S. Sales and Marketing 485 Half Day Road, Suite 400 1-844-4TOLMAR (1-844-486-5627) Buffalo Grove, IL 60089 info@tolmar.com To place an order or contact customer service for ELIGARD® (leuprolide acetate for injectable suspension), call 1-877-ELIGARD To report an adverse event, please call 1-888-ELIGARD. Media Contacts Careers Tolmar Pharmacueticals, Inc. Footer menu Contact Drug Distribution Accreditation – Learn More Media Privacy Policy Site Map Terms & Conditions ©2018-2020 Tolmar Pharmaceuticals, Inc. All rights reserved. TOLMAR, ELIGARD, FENSOLVI and ATRIGEL are trademarks of the TOLMAR group. Third party trademarks, product names, and copyrights belong to their respective owners. Back to Top

Main navigation About Tolmar Science & Innovation Treatments Responsibility Careers News Contact ELIGARD® (leuprolide acetate for injectable suspension) ELIGARD® is a prescription drug, given by injection, for the management of advanced prostate cancer. It is designed to deliver leuprolide acetate at a controlled rate over a 1-, 3-, 4-, or 6-month therapeutic period. This product is a type of hormonal therapy known as “luteinizing hormone-releasing hormone” (LHRH) agonist and ELIGARD is the only LHRH agonist with the controlled-release ATRIGEL® Delivery System. ELIGARD is also the only drug of its kind administered directly under the skin. ELIGARD is marketed in four single-dose strengths: ELIGARD 7.5 mg: 1 month of therapy ELIGARD 22.5 mg: 3 months of therapy ELIGARD 30 mg: 4 months of therapy ELIGARD 45 mg: 6 months of therapy ELIGARD® (leuprolide acetate for injectable suspension) is a prescription drug, given by injection, for the management of advanced prostate cancer. However, there is no known cure for advanced prostate cancer. IMPORTANT SAFETY INFORMATION ELIGARD (leuprolide acetate for injectable suspension) is a medicine for managing advanced prostate cancer. It is not a cure for advanced prostate cancer. ELIGARD should not be used by anyone who is allergic to any drug that is in the same class as ELIGARD, or anyone who is allergic to any of the ingredients in ELIGARD. Please see Full Prescribing Information for additional important safety information Tolmar Pharmacueticals, Inc. Footer menu Contact Drug Distribution Accreditation – Learn More Media Privacy Policy Site Map Terms & Conditions ©2018-2020 Tolmar Pharmaceuticals, Inc. All rights reserved. TOLMAR, ELIGARD, FENSOLVI and ATRIGEL are trademarks of the TOLMAR group. Third party trademarks, product names, and copyrights belong to their respective owners. Back to Top